Document is current
Any future updates will be listed below
-
Authors
Iachkine, Jeanne
Buetti, Niccolò
de Grooth, Harm-Jan
Briant, Anaïs R.
Mimoz, Olivier
Mégarbane, Bruno
Mira, Jean-Paul
Valette, Xavier
Daubin, Cédric
du Cheyron, Damien
Mermel, Leonard A.
Timsit, Jean-François
Parienti, Jean-Jacques https://orcid.org/0000-0002-4774-5590
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01479153 at ClinicalTrials.govDocuments that mention this clinical trial
Development and validation of a multivariable model predicting the required catheter dwell time among mechanically ventilated critically ill patients in three randomized trials
https://doi.org/10.1186/s13613-023-01099-9
Development and validation of a multivariable prediction model of central venous catheter-tip colonization in a cohort of five randomized trials
https://doi.org/10.1186/s13054-022-04078-x
- License Information
-
More Information
Article History
Received: 19 October 2022
Accepted: 3 January 2023
First Online: 16 January 2023
Declarations
:
: The 3SITES study (NCT01479153) was approved by the Ethics Committee of the Caen University Hospital, the CLEAN study (NCT01629550) by the Ethics Committee of the Poitiers University Hospital and the DRESSING2 study (NCT01189682) by the Rhônes-Alpes-4 Ethics Committee. All procedures in the original studies were performed in accordance with the ethical standards of the research committees and with the 1964 Helsinki. Written informed consent was obtained from all participants or their surrogates for all three RCTs.
: Not applicable.
: JI no conflict; N.B. no conflict; HJdG. no conflict; AB no conflict; OM. received research grants, lecture and consultancy fees from CareFusion; BM no conflict; JPM has no conflict directly related to the article but served on the scientific board of MSD, LFB and ASAI and Astellas; CD no conflict; XV no conflict; DdC. no conflict; LM served as an advisor/consultant for Citius Pharmaceuticals, Leonard-Meron Biosciences, and Destiny Pharma; JFT. has no conflict directly related to the article but serves on the advisory boards of MSD, Pfizer, Bayer pharma and Nabriva, has given lectures at MSD, Pfizer, Biomerieux, and his university or research team had received research grants from Pfizer and MSD; JJP. no conflict.
